170 related articles for article (PubMed ID: 24162602)
1. [Regulation of bone metabolisms by estrogen/estrogen receptors signaling].
Imai Y
Clin Calcium; 2013 Nov; 23(11):1621-6. PubMed ID: 24162602
[TBL] [Abstract][Full Text] [Related]
2. [Effects of SERMs on bone health. Mechanisms of bone mass control by selective estrogen receptor modulator].
Imai Y; Kato S
Clin Calcium; 2010 Mar; 20(3):339-44. PubMed ID: 20190363
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical markers of bone turnover. New aspect. Effects of androgen and estrogen on biochemical markers of bone turnover].
Ohnaka K; Takayanagi R
Clin Calcium; 2009 Aug; 19(8):1118-24. PubMed ID: 19638695
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-alpha.
Callewaert F; Venken K; Ophoff J; De Gendt K; Torcasio A; van Lenthe GH; Van Oosterwyck H; Boonen S; Bouillon R; Verhoeven G; Vanderschueren D
FASEB J; 2009 Jan; 23(1):232-40. PubMed ID: 18809737
[TBL] [Abstract][Full Text] [Related]
5. Selective estrogen receptor modulator inhibits osteocyte apoptosis during abrupt estrogen withdrawal: implications for bone quality maintenance.
Huber C; Collishaw S; Mosley JR; Reeve J; Noble BS
Calcif Tissue Int; 2007 Aug; 81(2):139-44. PubMed ID: 17638036
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanisms of postmenopausal osteoporosis].
Imai Y; Nakamura T; Takaoka K; Kato S
Nihon Ronen Igakkai Zasshi; 2009 Mar; 46(2):117-20. PubMed ID: 19491511
[No Abstract] [Full Text] [Related]
7. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.
Melville KM; Kelly NH; Khan SA; Schimenti JC; Ross FP; Main RP; van der Meulen MC
J Bone Miner Res; 2014 Feb; 29(2):370-9. PubMed ID: 24038209
[TBL] [Abstract][Full Text] [Related]
8. [Estrogens and selective estrogen receptor modulators in the treatment of osteoporosis].
Ribot C; Tremollieres F; Pouilles JM
Ann Med Interne (Paris); 2000 Oct; 151(6):490-6. PubMed ID: 11104929
[TBL] [Abstract][Full Text] [Related]
9. Post-menopausal osteoporosis.
Marcus R
Best Pract Res Clin Obstet Gynaecol; 2002 Jun; 16(3):309-27. PubMed ID: 12099665
[No Abstract] [Full Text] [Related]
10. [Status of novel bone-targeting SERMs in development].
Ohta H
Nihon Rinsho; 2007 Nov; 65 Suppl 9():433-41. PubMed ID: 18161145
[No Abstract] [Full Text] [Related]
11. Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.
Stepan JJ; Alenfeld F; Boivin G; Feyen JH; Lakatos P
Endocr Regul; 2003 Dec; 37(4):225-38. PubMed ID: 15106819
[TBL] [Abstract][Full Text] [Related]
12. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
Ohta H
Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
[TBL] [Abstract][Full Text] [Related]
13. The bone mass density in postmenopausal women using hormonal replacement therapy in relation to polymorphism in vitamin D receptor and estrogen receptor genes.
Brodowska A; Starczewski A; Brodowski J; Szydłowska I; Nawrocka-Rutkowska J
Gynecol Endocrinol; 2009 May; 25(5):315-23. PubMed ID: 19903038
[TBL] [Abstract][Full Text] [Related]
14. [Raloxifene hydrochloride (Evista Tablet 60 mg) for postmenopausal osteoporosis: mode of action and clinical efficacy].
Kobayashi H; Hamaya E
Nihon Yakurigaku Zasshi; 2005 Jan; 125(1):37-48. PubMed ID: 15738620
[No Abstract] [Full Text] [Related]
15. [Hormone replacement and selective estrogen receptor modulators (SERMS) in the prevention and treatment of postmenopausal osteoporosis].
Pfeilschifter J
Orthopade; 2001 Jul; 30(7):462-72. PubMed ID: 11515185
[TBL] [Abstract][Full Text] [Related]
16. Estrogen receptors: therapies targeted to receptor subtypes.
Nilsson S; Gustafsson JÅ
Clin Pharmacol Ther; 2011 Jan; 89(1):44-55. PubMed ID: 21124311
[TBL] [Abstract][Full Text] [Related]
17. Estrogens maintain bone mass by regulating expression of genes controlling function and life span in mature osteoclasts.
Imai Y; Youn MY; Kondoh S; Nakamura T; Kouzmenko A; Matsumoto T; Takada I; Takaoka K; Kato S
Ann N Y Acad Sci; 2009 Sep; 1173 Suppl 1():E31-9. PubMed ID: 19751412
[TBL] [Abstract][Full Text] [Related]
18. A specific haplotype in the 3' end of estrogen-receptor alpha gene is associated with low bone mineral density in premenopausal women and increased risk of postmenopausal osteoporosis.
Ongphiphadhanakul B; Chanprasertyothin S; Saetung S; Rajatanavin R
Osteoporos Int; 2005 Oct; 16(10):1233-8. PubMed ID: 15647972
[TBL] [Abstract][Full Text] [Related]
19. [Selective estrogen receptor modulators (SERMs)].
Chaki O
Nihon Rinsho; 2015 Oct; 73(10):1673-81. PubMed ID: 26529929
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor alpha gene polymorphisms are associated with changes in bone remodeling markers and treatment response to estrogen.
Rapuri PB; Gallagher JC; Knezetic JA; Haynatzka V
Maturitas; 2006 Mar; 53(4):371-9. PubMed ID: 16139450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
